analysis

An insight into the NIHR Health Informatics Collaborative

Safety and efficacy of blinatumomab and inotuzumab ozogamicin in multiple relapsed ALL

An analysis of shared treatment decision-making in patients with R/R DLBCL

Real-world analysis: molecular monitoring and adherence patterns to TKIs in older patients with CML

Changes in myeloma treatment following implementation of the IMWG criteria

ANDROMEDA trial: D-VCd versus VCd in the treatment of patients with newly diagnosed AL amyloidosis

Twitter: expediting critical research analysis

Midostaurin: the first drug to receive approval for AML since 2000

Current understandings of ALL approaches

Challenges with the identification of ALL subtypes

Multiple myeloma highlights at ASH 2017

Myeloma XI trial: impact of MRD on treatment response in MM

Results of the MURANO study for CLL

ASH 2017: CLL combination therapy highlights

“Sequential triple-T” therapy for CLL

Impacts of the MURANO study for future CLL treatment